LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 70.81 | 84.90 | 4151 | 9132 | 0.4546 | 0.7795 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 70.81 | 84.90 | 4183 | 9132 | 0.4581 | 0.7815 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 70.81 | 84.90 | 604 | 9132 | 0.0661 | 0.3374 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 70.81 | 84.90 | 5399 | 9132 | 0.5912 | 0.8502 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 72.52 | 84.90 | 4300 | 9214 | 0.4667 | 0.7868 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 72.52 | 84.90 | 4331 | 9214 | 0.4700 | 0.7887 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 72.52 | 84.90 | 678 | 9214 | 0.0736 | 0.3597 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 72.52 | 84.90 | 5680 | 9214 | 0.6164 | 0.8619 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 74.22 | 84.90 | 4356 | 9343 | 0.4662 | 0.7872 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 74.22 | 84.90 | 4397 | 9343 | 0.4706 | 0.7896 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 74.22 | 84.90 | 578 | 9343 | 0.0619 | 0.3269 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 74.22 | 84.90 | 5776 | 9343 | 0.6182 | 0.8631 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 75.93 | 84.90 | 4492 | 8970 | 0.5007 | 0.8045 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 75.93 | 84.90 | 4531 | 8970 | 0.5051 | 0.8068 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 75.93 | 84.90 | 516 | 8970 | 0.0575 | 0.3079 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 75.93 | 84.90 | 5906 | 8970 | 0.6584 | 0.8795 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 77.64 | 84.90 | 4576 | 9245 | 0.4949 | 0.8026 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 77.64 | 84.90 | 4622 | 9245 | 0.4999 | 0.8052 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 77.64 | 84.90 | 612 | 9245 | 0.0662 | 0.3390 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 77.64 | 84.90 | 5990 | 9245 | 0.6479 | 0.8757 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 79.34 | 84.90 | 4608 | 9051 | 0.5091 | 0.8093 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 79.34 | 84.90 | 4662 | 9051 | 0.5151 | 0.8124 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 79.34 | 84.90 | 539 | 9051 | 0.0595 | 0.3157 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 79.34 | 84.90 | 6225 | 9051 | 0.6877 | 0.8919 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 81.05 | 84.90 | 4651 | 8863 | 0.5247 | 0.8166 | MN20160318_Q02 | C03 |